NYSE:DHR 21 October 2025 - 15 February 2026

Danaher Corporation ended Wednesday, Dec. 24, 2025 on a quiet note in a holiday-shortened session, then drifted only slightly in after-hours trading. With U.S. markets closed on Christmas Day and set to reopen Friday, Dec. 26, the key “overnight” story for Danaher is less about a dramatic after-hours move — and more about calendar-driven factors and a handful of headline items investors may see circulating before the next open. New York Stock Exchange+1

Danaher Corporation is back in the spotlight on Monday, December 15, 2025, after two fresh Wall Street updates pushed Danaher stock back into the “what’s next” conversation for life-science and diagnostics investors. In afternoon trading, DHR hovered around $227 per share, modestly higher on the day.

Danaher Corporation is trading near the $231 level on Friday, Dec. 12, 2025, as fresh valuation takes, analyst coverage, and institutional positioning keep the life-sciences and diagnostics leader on investors’ screens. Here’s a complete roundup of today’s key developments, the newest forecasts, and the catalysts that could shape DHR’s next move.

As Wall Street heads into the first trading session of December, Danaher Corporation is entering Monday’s open with a stable share price, strong institutional backing and broadly positive—but valuation‑sensitive—analyst sentiment. Over the November 28–30 window, the news flow around Danaher has focused on a new shareholder-rights investigation, fresh institutional 13F filings, and updated price targets and quantitative forecasts that set the stage for how DHR may trade into year‑end. MarketBeat+2PR Newswire+2